Human Whole Genome Sequencing

from $59/sample

(A limited time offer)

 

Request a Free Quote

DNBSEQTM WGS

Here at BGI, customer service and satisfaction is at the heart of what we do. With more than two decades of experience delivering Whole Genome Sequencing (WGS) projects to customers across the world, we are the only DNBSEQTM-based WGS service provider in the US since 2017 and are proud of our well proven DNBSEQTM sequencing technology and complete WGS portfolio: Screen Shot 2022-08-10 at 2.35.45 PM

For a limited time, we are offering our human WGS at these special prices:

Picture1-4

Read on for more detail about our whole genome sequencing services. Request a consultation or no-obligation quote today, and we're sure you won't be disappointed!

 

Why Choose BGI's WGS Service?

20 years of Global WGS project experience comprising 600,000+ samples.

Guaranteed data quality at unbeatable pricing enabled by proprietary technology.

Rapid turnaround times, global service, no project too big or small.

WGS Service Overview

P3

Sample
Overview

Regular Samples:
  • Intact genomic DNA 1μg
  • Concentration 12.5ng/μl
  • Volume 15μl

    Low Input Samples:
  • Intact genomic DNA ≥ 200ng,
  • Concentration ≥ 2.5ng/μl.
P5

Sequencing
Standards

  • PE100 or PE150
  • Guaranteed 80% of bases with quality score of Q30
  • Standard sequencing coverage 30X/90Gb data (60X is recommended for cancer samples)
P6

Key Service
Details

  • Typical 10 working days from sample QC acceptance to delivery
  • Expedited services are available, contact your local BGI specialist for details
  • Reports and output data files are delivered in industry-standard file formats: BAM, .xls, .png, and FASTQ data.
Download Service Overview
Contact Us

Please tell us about your project, ask us a question, or request a free no-obligation quote. We are always happy to help.

Our DNBSEQ™ Sequencing Technology

BGI WGS services are typically executed with our proprietary DNBSEQ™ NGS technology platform, for great sequencing data at the lowest cost in the industry.

DNBSEQ is a proprietary sequencing technology, first developed by BGI's Complete Genomics subsidiary in Silicon Valley, and can offer advantages in terms of lower amplification error rates and much lower duplication rates for some sequencing applications. In addition, studies have shown the index hopping rate in DNBSEQ platforms can be much lower when compared to that of other platforms.

Terms and Conditions

  • This promotion includes library construction, sequencing, and standard bioinformatics analysis.
  • Sequencing performed on DNBSEQTM, PE100/PE150.
  • 3G is only available for PCR-based library.
  • Services are for research use only.
  • This promotion cannot be accumulated with any other offers.
  • These promotion terms are only eligible for contracts signed by October 15, 2022.
  • This is a limited and conditional offer subject to the actual execution of contract and BGI reserves the right to void the promotion.